Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

  • Martínez Aranda, Antonio
  • Hernández, Vanessa
  • Guney, Emre|||0000-0002-3466-6535
  • Muixí, Laia
  • Foj Ibars, Rubén
  • Baixeras, Núria
  • Cuadras, Daniel|||0000-0001-8780-1764
  • Morros, Rosa|||0000-0001-6752-8748
  • Urruticoechea, Ander|||0000-0003-0359-3641
  • Gil, Miguel
  • Oliva Miguel, Baldomero|||0000-0003-0702-0250
  • Moreno, Ferran
  • González Suarez, Eva
  • Vidal, Noemí|||0000-0002-2852-6667
  • Andreu, Xavier
  • Seguí Palmer, Miguel Ángel|||0000-0002-5103-6746
  • Ballester Alabau, Rosa María
  • Castellà Fernández, Eva
  • Sierra-Jimenez, Angels|||0000-0003-1023-3492
Brain metastasis is a devastating problem in patients with breast, lung and melanoma tumors. GRP94 and FN14 are predictive biomarkers over-expressed in primary breast carcinomas that metastasized in brain. To further validate these brain metastasis biomarkers, we performed a multicenter study including 318 patients with breast carcinomas. Among these patients, there were 138 patients with metastasis, of whom 84 had brain metastasis. The likelihood of developing brain metastasis increased by 5.24-fold (95%CI 2.83-9.71) and 2.55- (95%CI 1.52-4.3) in the presence of FN14 and GRP94, respectively. Moreover, FN14 was more sensitive than ErbB2 (38.27 vs. 24.68) with similar specificity (89.43 vs. 89.55) to predict brain metastasis and had identical prognostic value than triple negative patients (p 0.0001). Furthermore, we used GRP94 and FN14 pathways and GUILD, a network-based disease-gene prioritization program, to pinpoint the genes likely to be therapeutic targets, which resulted in FN14 as the main modulator and thalidomide as the best scored drug. The treatment of mice with brain metastasis improves survival decreasing reactive astrocytes and angiogenesis, and down-regulate FN14 and its ligand TWEAK. In conclusion our results indicate that FN14 and GRP94 are prediction/prognosis markers which open up new possibilities for preventing/treating brain metastasis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

RecA protein plays a role in the chemotactic response and chemoreceptor clustering of Salmonella enterica

  • Mayola Coromina, Albert
  • Irazoki Sánchez, Oihane
  • A. Martínez, Ignacio
  • Petrov, Dmitri A.
  • Menolascina, Filippo
  • Stocker, Roman
  • Reyes-Darias, José A.
  • Krell, Tino
  • Barbé García, Jordi|||0000-0003-4408-013X
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
The RecA protein is the main bacterial recombinase and the activator of the SOS system. In Escherichia coli and Salmonella enterica sv. Typhimurium, RecA is also essential for swarming, a flagellar-driven surface translocation mechanism widespread among bacteria. In this work, the direct interaction between RecA and the CheW coupling protein was confirmed, and the motility and chemotactic phenotype of a S. Typhimurium DrecA mutant was characterized through microfluidics, optical trapping, and quantitative capillary assays. The results demonstrate the tight association of RecA with the chemotaxis pathway and also its involvement in polar chemoreceptor cluster formation. RecA is therefore necessary for standard flagellar rotation switching, implying its essential role not only in swarming motility but also in the normal chemotactic response of S. Typhimurium.